Health Condition 1: M169- Osteoarthritis of hip, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients aged between 18-70 years with unilateral symptomatic hip arthritis undergoing unilateral cementless THA.
Exclusion criteria
Exclusion criteria: 1. Patients with previous prosthetic hip replacement devices/ revision surgeries. 2. Patients aged less than 18 years or more than 70 years. 3. Patients with the presence of infections- highly communicable diseases like AIDS, venereal diseases, hepatitis, pulmonary tuberculosis. 4. Patients undergoing simultaneous hip and knee arthroplasty. 5. Patients not giving consent. 6. Patient having contralateral symptomatic hip arthritis. 7. Patients with Crowe 3 and 4 hip dysplasias. 8. Patients with neuromuscular disorders or musculoskeletal disorders or diseases that may adversely affect normal weight bearing or gait 9. Patients with active major psychiatric illness or active metastatic disease. 10. Patients with spinopelvic involvement and difference in sacral slope in standing and sitting lateral spine x ray less than 10º.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the clinical and radiological outcomes of THA with direct anterior approach (DAA) versus posterior approach.Timepoint: Preoperative period upto 1 year of Postoperative follow up, including regular follow ups at 2 weeks, 6 weeks, 3 months and 1 year. | — |
Secondary
| Measure | Time frame |
|---|---|
| • To compare tissue damage between Direct Anterior Approach (DAA) versus Posterior Approach THA by blood tests and MRI. • To compare functional outcomes between DAA vs Posterior approach THA using patient reported outcome scores and Gait analysis. • To compare rate of return to activities of daily living using a milestone diary. • To compare the radiological outcomes between the two groups for optimal implant positioning and leg length using standard radiographs and EOSTM scan.Timepoint: Preoperative period upto 1 year of Postoperative follow up, including regular follow ups at 2 weeks, 6 weeks, 3 months and 1 year. | — |
Countries
India
Contacts
AIIMS New Delhi